Cerveau Technologies

Provider of information and technology for researchers and clinicians in neurodegenerative disease research, enabling molecular imaging and biomarker access.

Provider of information and technology to researchers and clinicians intended to treat neurodegenerative diseases. The company offers broad access to biomarkers of neurological pathologies, essential enabling tools and information technology to revolutionize the use of molecular imaging, helping healthcare industries to accelerate the development and approval of effective therapies to treat Alzheimer's and other neurodegenerative diseases.

Partnerships